Porphyria cutanea tarda, dermatomyositis and non-Hodgkin lymphoma in virus C infection

European Journal of Dermatology

Volumn 13, Issue 3, 2003, Pages 302-304

  Bauza A ^a   Espana A ^a   Lloret, P ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Dermatomyositis; Lymphoma; Porphyria cutanea tarda; Virus C

Indexed keywords

ANTINUCLEAR ANTIBODY; COPROPORPHYRIN; CREATINE KINASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FRUCTOSE BISPHOSPHATE ALDOLASE; LACTATE DEHYDROGENASE; PORPHOBILINOGEN; PREDNISONE; UROPORPHYRIN; VINCRISTINE;

ADULT; ANTIBODY TITER; ARM; ARTICLE; BLISTER; CANCER CHEMOTHERAPY; CASE REPORT; COMORBIDITY; CRYOGLOBULINEMIA; DERMATOMYOSITIS; DISEASE ASSOCIATION; DYSPHAGIA; ELBOW; ENZYME ASSAY; HAND; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPERTRICHOSIS; INFLAMMATORY INFILTRATE; INTERPHALANGEAL JOINT; LIVER; LIVER FUNCTION TEST; LUPUS ERYTHEMATOSUS; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; METACARPOPHALANGEAL JOINT; MONOCLONAL IMMUNOGLOBULINEMIA; MUSCLE LEVEL; MUSCLE WEAKNESS; NEOPLASM; NEUTROPHIL CHEMOTAXIS; NONHODGKIN LYMPHOMA; PELVIS; POIKILODERMA; PORPHYRIA CUTANEA TARDA; RHEUMATOID ARTHRITIS; RISK FACTOR; SCAPULA; SKIN BIOPSY; SPLEEN; TELANGIECTASIA; THROMBOSIS; URINALYSIS; VASCULITIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARM; CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; HAND; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; PREDNISONE; VINCRISTINE;

EID: 0037863770     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mc Murray RW, Elbourne K. Hepatitis C Virus Infection and Autoimmunity. Semin Arthritis Rheum 1997; 26: 689-71.
2. Bonkovsky HL, Mehta S. Hepatitis C. A review ond update. J Am Acad Dermatol 2001; 44: 159-79.
3. Chuong TY, Brashear R, Lewis C. Porphyrio cutanea tarda and hepatitis C virus: a case-control study and meta-analysis of the literature. J Am Acad Dermatol 1999; 41 (1): 31-6.
4. Nishikai M, Miyairi M, Kosaba S. Dermatomyositis following infection with hepatitis C virus (letter: comment). J Rheumatol 1994; 21: 1584-5.
5. Useno Y, Kondo K, Kidodoro N, et al. Hepatitis C infection and polymyositis (letter comment). Lancet 1995; 346: 319-20.
6. Cox NH, Lawrence CM, Langtry JAA, et al. Dermotomyositis. Arch Dermatol 1990; 126: 61-5.
7. Dandurand M, Guillot B, Guihou JJ. Porphyrio cutanea tordo and neoplasms. A propos of 2 cases. Ann Dermatol Venereol 1986; 113 (8): 679-83.
8. Loi CL, Wu PC, Lin HJ, Wong KL. Case report of symptomatic porphyria cutaneo tarda associated with histiocytic lymphoma. Concer 1984; 53 (3): 573-6.
9. Cram DL, Epstein J, Tuffanelli DL. Lupus Erythematosus and Porphyria.: coexistence in seven patients. Arch Dermatol 1973; 108: 779-84.
10. Belaich S, Crickx B, Picard C, et al. Porphyria cutanea tarda associated with pure cutaneous dermatomyositis. Ann Dermatol Veneorol 1989; 116: 826-7.
11. Furuta M, et al. Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels. J Gastroenterol 2000; 35: 60-2.
12. Dietrich LL, Bridges AJ, Albertini MR. Dermatomyositis after interferon alpha treatment. Med Oncol 2000; 17: 64-9.
13. Sacchi S, Kantarjian H, O'Brien S, Cohen PR, Pierce S, Talpaz M. Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 1995; 13: 2401-7.
14. Hadziyannis SJ. Non-hepatic manifestations and combined diseases in HCV infection. Dig Dis Sci 1996; 41: 63S-74S.